-
December 23, 2024
Xeureka Held the Second Executive Board Meeting of Tokyo-1READ MORE
-
November 21, 2024
Sponsored Session at the CBI Annual Meeting 2024: “Accelerating Drug Discovery Innovation in the Tokyo-1 Community: The Future of Drug Discovery Unlocked by Cutting-Edge GPU Computing”READ MORE
-
November 18, 2024
Our CTO, Hiroki Makiguchi, Takes the Stage at BioJapan-Hosted Seminar: “The AI Revolution in Drug Discovery”READ MORE
-
August 21, 2024
Notice of Address ChangeREAD MORE
-
August 07, 2024
Xeureka begins AI drug discovery support for FunPep research on antibody-inducing peptidesREAD MORE
-
May 02, 2024
【Case study】Target AnalysisREAD MORE
-
March 28, 2024
Xeureka Held the First Executive Board Meeting of Tokyo-1READ MORE
-
February 01, 2024
Mitsui & Co. Subsidiary, Xeureka, Launches Tokyo-1 Project Propelling AI-Driven Drug DiscoveryREAD MORE
-
May 31, 2023
Xeureka Accelerates AI Drug Discovery with Cutting-edge Supercomputer Powered by NVIDIA, Launches Tokyo-1 Project for Leading Pharmaceutical Companies in JapanREAD MORE
